Core Insights - Lecheng Bio has launched the Extreme™ PVDF sterilizing filter membrane, which boasts high purity, high flux, and low protein adsorption, achieving leading performance parameters in the market [1] - The PVDF series sterilizing filters are a key product focus for Lecheng Bio this year, with significant improvements in filtration capacity and minimal flux decline during the filtration process, enhancing production efficiency and shortening process cycles [1] - The company has also successfully developed PES hydrophobic filter membranes, with a complete range of hydrophilic and hydrophobic PES filter products already launched, and plans to introduce PES ultrafiltration membranes by the end of the year [1] Market Position - According to third-party industry research data, over 50% of disposable consumables and equipment in the biopharmaceutical R&D and production process have been domestically replaced, with Lecheng Bio holding a leading market share [1] - The domestic market share for filters is approximately 30%, while the share for culture media is around 20%, with Lecheng Bio being an early mover in these segments and maintaining a competitive advantage [1] - The company aims to introduce PVDF sterilizing and virus filter membranes into the market, alongside launching domestic virus filters for blood products and high-concentration protein solutions [2]